I
Inscopix
Inscopix is pioneering a new paradigm in the quest to understand the brain and its diseases
About Inscopix
Inscopix is a pioneering company in the field of neuroscience, specializing in the development and provision of miniature microscope solutions for real-time brain mapping. The company’s primary product is a "miniscope," a small, advanced microscope used for calcium imaging and manipulation of neural activity in brain circuits during behavior. This technology allows researchers to observe and understand how different parts of the brain communicate and function in real-time.
Inscopix serves a diverse range of clients, including academic researchers, industry scientists, and early career investigators. Their clients span from Nobel Prize winners to up-and-coming scientists, all working to push the boundaries of brain science. The company operates in the neuroscience research market, which is a niche but rapidly growing field focused on understanding the complexities of the brain.
The business model of Inscopix revolves around selling their innovative miniscopes and providing comprehensive support services. They offer intuitive software for data analysis, training workshops, field scientific consultations, and a knowledge base to help researchers maximize the potential of their tools. Additionally, Inscopix assists researchers in securing grants, which can be crucial for funding their scientific endeavors.
Inscopix generates revenue primarily through the sale of their miniature microscopes and associated software. They also monetize their support services, which are designed to ensure that researchers can effectively use their products and achieve successful outcomes in their studies. By providing a complete solution—from cutting-edge technology to expert support—Inscopix helps accelerate the pace of discoveries in brain science.
Source: Dealroom company dataAt a glance
- Status
- Acquired
- Founded
- 2011
- Headquarters
- Mountain View, United States
- Employees
- 40
- Open positions
- None listed
- Dealroom signal
- 58.5/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Neurology, Core AI, Spinout, Biotech and Pharma, AI Applications, DT and LS, science-based
- Technology
- Artificial Intelligence, Deep Tech, Computer Vision
- Client focus
- b2c
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITION✓Exit | Nov 2022 | $0 | — | Bruker | ↗ |
| SERIES A✓Equity / VC | Aug 2016 | $10M | $40M | AME Cloud Ventures · Floodgate · Playground Global | — |
Growth signals
Latest recorded traffic for Inscopix is 6.4K monthly website visits, up 45.5% over the last three months. Inscopix's team declined 50% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
Playground Global
AME Cloud Ventures
Floodgate
Other known investors4 additional known investors
Bruker
Stanford University
Technology Pioneers | World Economic Forum
Western Technology Investment
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Inscopix on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Inscopix’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







